The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease.

Awahara, Chiyuki; Oku, Daiki; Furuta, Saki; Kobayashi, Kazuya; Teruya, Kenta; Akaji, Kenichi; Hattori, Yasunao

Awahara, Chiyuki; Oku, Daiki; Furuta, Saki; Kobayashi, Kazuya; Teruya, Kenta; Akaji, Kenichi; Hattori, Yasunao.

Afiliação

Awahara C; Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.
Oku D; Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.
Furuta S; Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.
Kobayashi K; Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.
Teruya K; Department of Neurochemistry, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8575, Japan.
Akaji K; Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.
Hattori Y; Center for Instrumental Analysis, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan.

Molecules ; 27(5)2022 Mar 02.

Article em En | MEDLINE | ID: mdl-35268749

Assuntos

Peptídeo Hidrolases

Palavras-chave

HTLV-1 protease; hydroxyethylamine isostere; inhibitor; retroinverso conversion

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeo Hidrolases Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google